The effect of elranatamab against multiple myeloma cells is mediated by CD8+ cells

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Takaaki Takeda, Kota Kawabata, Ayako Bouno, Yuki Nakajima, Katsumichi Fujimaki, Hideaki Nakajima
DOI: 10.2139/ssrn.6043266
Cited by: 1

Fields of Study & Subjects

Multiple Myeloma Research and Treatments CAR-T cell therapy research Immunotherapy and Immune Responses

Publication details

Journal / source
SSRN Electronic Journal
Publisher
Elsevier BV
Publication date
1 January 2026
Document type
Preprint